Current Trends in Microfluidics and Biosensors for Cancer Research Applications

last updated: 2022-06-28
Project2MATCH :: publications list
TitleCurrent Trends in Microfluidics and Biosensors for Cancer Research Applications
Publication TypeBook Chapter
Year of Publication2022
AuthorsCaballero D., Reis R. L., and Kundu S. C.
EditorsCaballero D., Kundu S. C., and Reis R. L.
Abstract Text

Despite the significant amount of resources invested, cancer remains a considerable burden in our modern society and a leading cause of death. There is still a lack of knowledge about the mechanistic determinants of the disease, the mechanism of action of drugs, and the process of tumor relapse. Current methodologies to study all these events fail to provide accurate information, threatening the prognosis of cancer patients. This failure is due to the inadequate procedure in how tumorigenesis is studied and how drug discovery and screening are currently made. Traditionally, they both rely on seeding cells on static flat cultures and on the immunolabelling of cellular structures, which are usually limited in their ability to reproduce the complexity of the native cellular habitat and provide quantitative data. Similarly, more complex animal models are employed for—unsuccessfully—mimicking the human physiology and evaluating the etiology of the disease or the efficacy/toxicity of pharmacological compounds. Despite some breakthroughs and success obtained in understanding the disease and developing novel therapeutic approaches, cancer still kills millions of people worldwide, remaining a global healthcare problem with a high social and economic impact. There is a need for novel integrative methodologies and technologies capable of providing valuable readouts. In this regard, the combination of microfluidics technology with miniaturized biosensors offers unprecedented advantages to accelerate the development of drugs. This integrated technology have the potential to unravel the key pathophysiological processes of cancer progression and metastasis, overcoming the existing gap on in vitro predictive platforms and in vivo model systems. Herein, we discuss how this combination may boost the field of cancer theranostics and drug discovery/screening toward more precise devices with clinical relevance.

Book Title Microfluidics and Biosensors in Cancer Research. Advances in Experimental Medicine and Biology
KeywordsBiosensors, Cancer, Microfluidics
Peer reviewedyes

Back to top